Skip To Main Content
Manuel Brantner on Muck Rack

Manuel Brantner

As seen in: Bioprocess Online
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Manuel

Contact Manuel, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Manufacturing Strategies For mRNA Vaccines And Therapeutics

|
By Anissa Boumlic, Shiksha Mantri, Manuel Brantner, Bahar Cebi
| Bioprocess Online Verified
By Dr. Nargisse El Hajjami, Mag. Manuel Brantner, Anissa Boumlic, Shiksha Mantri, and Bahar Cebi Viral delivery systems such as adeno-associated virus (AAV) vectors are well established and approved for use as vaccines and gene therapies. Despite their widespread use, viral delivery systems can lead to immunogenicity and side effects. In addition, the manufacturing process can be complex and high titers are needed for gene therapy applications.
Open in Who Shared Issue with article?
See all 1 articles